ATP citrate lyase is an important component of cell growth and transformation

Oncogene

Volumn 24, Issue 41, 2005, Pages 6314-6322

  Bauer, Daniel E ^a   Hatzivassiliou, Georgia ^a   Zhao, Fangping ^a   Andreadis, Charalambos ^b   Thompson, Craig B ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Akt; ATP citrate lyase; Cell growth; Glucose metabolism; Lipid synthesis; Transformation

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE LYASE;

ARTICLE; BIOGENESIS; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; GLUCOSE TRANSPORT; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LIPOGENESIS; MEMBRANE BINDING; MEMBRANE POTENTIAL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ATP CITRATE (PRO-S)-LYASE; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; MOLECULAR SEQUENCE DATA;

EID: 30544433533     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208773     Document Type: Article

References (45)

1. Alli PM, Pinn ML, Jaffee EM, McFadden JM and Kuhajda FP. (2005). Oncogene, 24, 39-46.
2. Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, Rathmell JC, Riley JL and Thompson CB. (2004). FASEB J., 18, 1303-1305.
3. Beigneux AP, Kosinski C, Gavino B, Horton JD, Skarnes WC and Young SG. (2004). J. Biol. Chem., 279, 9557-9564.
4. Bellacosa A, Testa JR, Staal SP and Tsichlis PN. (1991). Science, 254, 274-277.
5. Bentley J, Itchayanan D, Barnes K, McIntosh E, Tang X, Downes CP, Holman GD, Whetton AD, Owen-Lynch PJ and Baldwin SA. (2003). J. Biol. Chem., 278, 39337-39348.
6. Berridge MV and Tan AS. (1995). Biochem. J., 305 (Part 3), 843-851.
7. Berwick DC, Hers I, Heesom KJ, Moule SK and Tavare JM. (2002). J. Biol. Chem., 277, 33895-33900.
8. Bligh EG and Dyer WJ. (1959). Can. J. Med. Sci., 37, 911-917.
9. Board M and Newsholme E. (1996). Biochem. Mol. Biol. Int., 40, 1047-1056.
10. Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK and Daling JR. (2004). Cancer, 100, 2308-2316.
11. Conlon I and Raff M. (1999). Cell, 96, 235-244.
12. Dang CV and Semenza GL. (1999). Trends. Biochem. Sci., 24, 68-72.
13. Deprez J, Vertommen D, Alessi DR, Hue L and Rider MH. (1997). J. Biol. Chem., 272, 17269-17275.
14. Dimitroulakos J, Nohynek D, Backway KL, Hedley DW, Yeger H, Freedman MH, Minden MD and Penn LZ. (1999). Blood, 93, 1308-1318.
15. Edinger AL, Cinalli RM and Thompson CB. (2003). Dev. Cell, 5, 571-582.
16. Edinger AL and Thompson CB. (2002). Mol. Biol. Cell, 13, 2276-2288.
17. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and Thompson CB. (2004). Cancer Res., 64, 3892-3899.
18. Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA and Thompson CB. (2003). Genes Dev., 17, 1841-1854.
19. Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C. (2003). Oncogene, 22, 8983-8998.
20. Gonin-Giraud S, Mathieu AL, Diocou S, Tomkowiak M, Delorme G and Marvel J. (2002). Cell Death Differ., 9, 1147-1157.
21. Gottlieb E, Armour SM, Harris MH and Thompson CB. (2003). Cell Death Differ., 10, 709-717.
22. Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ and Guchelaar HJ. (2004). J. Clin. Oncol., 22, 2388-2394.
23. Hedeskov CJ. (1968). Biochem. J., 110, 373-380.
24. Imesch E and Rous S. (1984). Int. J. Biochem., 16, 875-881.
25. Karnauskas R, Niu Q, Talapatra S, Plas DR, Greene ME, Crispino JD and Rudin CM. (2003). Oncogene, 22, 688-698.
26. Kohn AD, Summers SA, Birnbaum MJ and Roth RA. (1996). J. Biol. Chem., 271, 31372-31378.
27. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD and Pasternack GR. (1994). Proc. Natl. Acad. Sci. USA, 91, 6379-6383.
28. Luo J, Manning BD and Cantley LC. (2003). Cancer Cell, 4, 257-262.
29. McKearn JP, McCubrey J and Fagg B. (1985). Proc. Natl. Acad. Sci. USA, 82, 7414-7418.
30. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP and Korsmeyer SJ. (1990). J. Immunol., 144, 3602-3610.
31. Paddison PJ and Hannon GJ. (2002). Cancer Cell, 2, 17-23.
32. Pierce MW, Palmer JL, Keutmann HT and Avruch J. (1981). J. Biol. Chem., 256, 8867-8870.
33. Plas DR, Talapatra S, Edinger AL, Rathmell JC and Thompson CB. (2001). J. Biol. Chem., 276, 12041-12048.
34. Potapova IA, El-Maghrabi MR, Doronin SV and Benjamin WB. (2000). Biochemistry, 39, 1169-1179.
35. Price DJ, Nemenoff RA and Avruch J. (1989). J. Biol. Chem., 264, 13825-13833.
36. Russo P, Loprevite M, Cesario A and Ardizzoni A. (2004). Curr. Med. Chem. Anti-Cancer Agents, 4, 123-138.
37. Srere PA. (1959). J. Biol. Chem., 234, 2544-2547.
38. Srere PA. (1972). Curr. Top Cell. Regul., 5, 229-283.
39. Sullivan AC, Triscari J, Hamilton JG, Miller ON and Wheatley VR. (1974). Lipids, 9, 121-128.
40. Sumi S, Beauchamp RD, Townsend Jr CM, Uchida T, Murakami M, Rajaraman S, Ishizuka J and Thompson JC. (1992). Gastroenterology, 103, 982-989.
41. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH and Thompson CB. (2001). Mol. Cell. Biol., 21, 5899-5912.
42. Vivanco I and Sawyers CL. (2002). Nat. Rev. Cancer, 2, 489-501.
43. Warburg O. (1956). Science, 123, 309-314.
44. Whetton AD, Bazill GW and Dexter TM. (1985). J. Cell Physiol., 123, 73-78.
45. Yu KT, Benjamin WB, Ramakrishna S, Khalaf N and Czech MP. (1990). Biochem. J., 268, 539-545.